Deutsch English Français

Contact

EP1792178

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1792178

EP1792178 - CELLULAR FIBRONECTIN AS A DIAGNOSTIC MARKER IN STROKE AND METHODS OF USE THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 25.12.2009 Database last updated on 03.06.2024
Most recent event Tooltip	25.12.2009	Application deemed to be withdrawn	published on 27.01.2010 [2010/04]
Applicant(s)	For all designated states Prediction Sciences LLC 9404 Genesee Avenue, Suite 210 La Jolla CA 92037 / US
	[2007/23]
Inventor(s)	01 / CASTELLANO, Mar, Hospital Uni. de Girona Dept of Neurology Doctor Josep Trueta Avide Franca 17007 Girona / ES
	02 / DAVALOS, Antoni, Hospital Uni. de Girona Dept of Neurology Doctor Josep Trueta Avide Franca 17007 Girona / ES
	03 / DIAMOND, Cornelius, Allen, Prediction Sciences LLC 9404 Genesee Avenue Suite 210 La Jolla, CA 92037 / US
	[2007/23]
Representative(s)	Schnappauf, Georg, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE
	[N/P]
Former [2007/23]	Schnappauf, Georg, et al Dr. Volker Vossius Patent- und Rechtsanwaltskanzlei Geibelstrasse 6 81679 München / DE
Application number, filing date	05778919.0	18.05.2005
	[2007/23]
	WO2005US17274
Priority number, date	US20040948834	22.09.2004 Original published format: US 948834
	US20050046592	29.01.2005 Original published format: US 46592
	[2007/38]
Former [2007/23]	US20040948834	22.09.2004
	US20050046593	29.01.2005
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2006036220
	Date:	06.04.2006
	Language:	EN
	[2006/14]
	Type:	A2 Application without search report
	No.:	EP1792178
	Date:	06.06.2007
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 06.04.2006 takes the place of the publication of the European patent application.
	[2007/23]
Search report(s)	International search report - published on:	US	06.07.2006
	(Supplementary) European search report - dispatched on:	EP	30.08.2007
Classification	IPC:	G01N33/48, G01N33/50, G01N33/53, G06F19/00	[2007/23]
	CPC:	G01N33/6893 (EP,US); G01N33/6848 (EP,US); G16B20/20 (EP,US); G16B40/00 (EP,US); G16B40/10 (EP,US); G16B40/20 (EP,US); (+) G01N2333/78 (EP,US); G01N2800/2871 (EP,US); G16B20/00 (EP,US); Y02A90/10 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/23]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	YU	Not yet paid
Title	German:	ZELLULÄRES FIBRONECTIN ALS DIAGNOSTISCHER MARKER BEI SCHLAGANFALL SOWIE VERFAHREN ZUR VERWENDUNG DAVON	[2007/23]
	English:	CELLULAR FIBRONECTIN AS A DIAGNOSTIC MARKER IN STROKE AND METHODS OF USE THEREOF	[2007/23]
	French:	FIBRONECTINE CELLULAIRE EN TANT QUE MARQUEUR DIAGNOSTIQUE DANS L'ACCIDENT VASCULAIRE CEREBRAL ET SES PROCEDES D'UTILISATION	[2007/23]
Entry into regional phase	19.03.2007	National basic fee paid
	19.03.2007	Search fee paid
	19.03.2007	Designation fee(s) paid
	19.03.2007	Examination fee paid
Examination procedure	19.03.2007	Examination requested [2007/23]
	29.10.2007	Amendment by applicant (claims and/or description)
	11.02.2008	Despatch of a communication from the examining division (Time limit: M04)
	05.06.2008	Reply to a communication from the examining division
	19.03.2009	Despatch of a communication from the examining division (Time limit: M04)
	30.07.2009	Application deemed to be withdrawn, date of legal effect [2010/04]
	07.09.2009	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/04]
Fees paid	Renewal fee
	28.07.2008	Renewal fee patent year 04
	Penalty fee
	Additional fee for renewal fee
	31.05.2007	03 M06 Fee paid on 29.08.2007
	31.05.2008	04 M06 Fee paid on 28.07.2008
	31.05.2009	05 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]WO0206829 (CORRELOGIC SYSTEMS INC [US]) [Y] 1-19 * abstract * * page 8, line 9 - page 12, line 22 * * page 13 - page 24 * * claims 1-65 *;
		[Y]WO03025571 (KLEINFELD ALAN [US]) [Y] 14,16 * page 5, line 4 - page 6, line 23 * * example 4 ** claims 48-59 *;
		[Y]EP1394715 (EUROPROTEOME AG [DE]) [Y] 1-19 * abstract * * paragraphs [0004] - [0010] * * figure 1 * * paragraph [0014] * * paragraphs [0058] - [0063] *;
		[YD]US2004121343 (BUECHLER KENNETH F [US], et al) [YD] 1-23,29 * paragraphs [0023] - [0028] * * paragraphs [0111] , [0112] * * paragraphs [0162] - [0204] * * paragraphs [0213] - [0221] * * claims 1-57 * * paragraphs [0048] , [0051] * * paragraphs [0068] - [0083] *;
		[Y] - CASTELLANOS MAR ET AL, "Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke", STROKE, (200407), vol. 35, no. 7, ISSN 0039-2499, pages 1671 - 1676, XP002444804 [Y] 1-29 * the whole document * DOI: http://dx.doi.org/10.1161/01.STR.0000131656.47979.39
		[Y] - FRIJNS CATHARINA J M ET AL, "Endothelial cell activation after subarachnoid hemorrhage", NEUROSURGERY (BALTIMORE), (200206), vol. 50, no. 6, ISSN 0148-396X, pages 1223 - 1230, XP008081877 [Y] 1-29 * the whole document * DOI: http://dx.doi.org/10.1097/00006123-200206000-00009
		[Y] - SEIJO-MARTINEZ MANUEL ET AL, "Molecular markers of inflammation and blood-brain barrier rupture as potential predictive factors of early hemorrhage growth", NEUROLOGY, & 56TH ANNUAL MEETING OF THE AMERICAN-ACADEMY-OF-NEUROLOGY; SAN FRANCISCO, CA, USA; APRIL 24 -MAY 01, 2004, (200404), vol. 62, no. 7, Suppl. 5, ISSN 0028-3878, pages A100 - A101, XP008081874 [Y] 1-29 * the whole document *
	International search	[A]US2003100010 (JACKOWSKI GEORGE [CA], et al);
		[A] - IRION O. ET AL., "CAN CIRCULATING CELLULAR FIBRONECTIN PREDICT LABOR?", BIOSIS, Database accession no. (PREV199242085239), XP002996466
		[ ] - AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, (1992), vol. 166, no. 1, PART 2, page 377
		[A] - ZHANG J. ET AL., "Maternal plasma cellular fibronectin for early prediction of preeclampsia", EMBASE, Database accession no. (2003454474), XP002996467
		[ ] - AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, (2003), vol. 189, no. 4, page 1212
		[A] - HEGELE A. ET AL., "Plasma levels of cellular fibronectin in patients with localized and metastatic renal cell carcinoma", CAPLUS, Database accession no. (2004:746703), XP002996469
		[ ] - TUMOR BIOLOGY, (2004), vol. 25, no. 3, pages 111 - 116

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p